https://pharmadog.xyz/news/294767 pharmadog en 2026-08-21T17:04:26.000Z Capricor shareholders face board overhaul push as investors demand meeting and capital-preservation plan amid DMD cell therapy delay https://pharmadog.xyz/news/294635 pharmadog en 2026-08-21T16:50:51.000Z HHS Secretary RFK Jr. seeks to soften U.S. vaccine recommendations https://pharmadog.xyz/news/294679 pharmadog en 2026-08-21T16:40:03.000Z HHS seeks public input on new vaccine recommendation categories under Trump and Kennedy https://pharmadog.xyz/news/294242 pharmadog en 2026-08-21T15:24:23.000Z California chronic pain biotech co‑founded by Vivek Ramaswamy to go public via reverse merger https://pharmadog.xyz/news/294035 pharmadog en 2026-08-21T14:52:26.000Z Genentech pours $750M into new drug‑delivery device plant in Oregon; Bavarian Nordic pushes back Lyme vaccine trial https://pharmadog.xyz/news/294059 pharmadog en 2026-08-21T14:37:32.000Z US lawmakers push FDA to tighten rules on Chinese clinical data after three gene therapy deaths https://pharmadog.xyz/news/294060 pharmadog en 2026-08-21T14:27:37.000Z Werewolf Therapeutics merges with Ambros in $150M deal to advance non‑opioid painkiller for rare limb injury syndrome https://pharmadog.xyz/news/293852 pharmadog en 2026-08-21T13:51:51.000Z Spruce Biosciences appoints former Zevra Therapeutics CMO Adrian Quartel https://pharmadog.xyz/news/293853 pharmadog en 2026-08-21T13:40:19.000Z Roche's Genentech to invest $750 million to double Oregon manufacturing site https://pharmadog.xyz/news/294099 pharmadog en 2026-08-21T13:30:00.000Z Activist Kaos Capital pushes governance overhaul at Capricor ahead of FDA Duchenne decision https://pharmadog.xyz/news/293854 pharmadog en 2026-08-21T13:23:49.000Z Study suggests cancer patients may be receiving higher doses and longer treatment courses than needed https://pharmadog.xyz/news/293656 pharmadog en 2026-08-21T13:04:41.000Z Merck’s Ebola vaccine rolled out in the Democratic Republic of Congo https://pharmadog.xyz/news/293543 pharmadog en 2026-08-21T13:00:16.000Z New study warns that Trump-era cuts to federal research could jeopardize cancer drug development https://pharmadog.xyz/news/293311 pharmadog en 2026-08-21T11:44:07.000Z Novo Nordisk launches Phase 3 trial of lower maintenance doses of oral Wegovy for obesity https://pharmadog.xyz/news/292968 pharmadog en 2026-08-21T11:00:51.000Z GOP lawmakers urge FDA to reject Chinese trial data unless sites undergo recent agency audit https://pharmadog.xyz/news/292969 pharmadog en 2026-08-21T11:00:44.000Z Replimune appoints former Genentech exec Michelle DiNapoli as chief commercial officer after accelerated melanoma approval https://pharmadog.xyz/news/293032 pharmadog en 2026-08-21T11:00:00.000Z Lilly leads GLP-1 weight-loss market while Novo Nordisk’s Wegovy exceeds expectations but falls short of forecasts https://pharmadog.xyz/news/293734 pharmadog en 2026-08-21T09:15:00.000Z Ambros Therapeutics merges with Werewolf, raises $150M to fund phase 3 trial of rare disease drug https://pharmadog.xyz/news/292389 pharmadog en 2026-08-21T08:30:00.000Z Cure for HIV must protect long-term survivors from loss of benefits https://pharmadog.xyz/news/292388 pharmadog en 2026-08-21T08:30:00.000Z Lil Nas X’s bipolar diagnosis highlights the fear many high achievers have of mental-health treatment https://pharmadog.xyz/news/292387 pharmadog en 2026-08-21T08:30:00.000Z New study shows focal therapy matches surgery and radiation survival while reducing side effects in localized prostate cancer https://pharmadog.xyz/news/288815 pharmadog en 2026-08-20T19:30:51.000Z Roche commits $750 million to double Oregon plant capacity as obesity drug push grows https://pharmadog.xyz/news/288575 pharmadog en 2026-08-20T18:26:03.000Z PhRMA weighs former Republican lawmakers and Trump administration officials for CEO role https://pharmadog.xyz/news/288576 pharmadog en 2026-08-20T18:05:41.000Z Three deaths in China’s investigator-initiated trials raise concerns over fast, low-cost clinical testing https://pharmadog.xyz/news/288324 pharmadog en 2026-08-20T17:38:03.000Z FDA rejects Osteal Therapeutics' combo therapy for joint-implant infections https://pharmadog.xyz/news/287911 pharmadog en 2026-08-20T16:21:25.000Z Regeneron wins FDA approval for Pasatru, targeting rare bone disease FOP https://pharmadog.xyz/news/287547 pharmadog en 2026-08-20T15:19:46.000Z Moderna’s melanoma vaccine trial success sparks $45 billion market value surge https://pharmadog.xyz/news/287548 pharmadog en 2026-08-20T15:13:00.000Z Ultragenyx secures FDA approval for Glenglycos, first gene therapy for GSD Ia https://pharmadog.xyz/news/287582 pharmadog en 2026-08-20T15:12:43.000Z Gray‑market copies of Lilly’s obesity drug retatrutide show weaker weight‑loss results, study finds https://pharmadog.xyz/news/292318 pharmadog en 2026-08-20T15:10:00.000Z Boehringer Ingelheim pauses phase 1 trial of BI 3031185 in Japan to investigate safety event https://pharmadog.xyz/news/293518 pharmadog en 2026-08-20T15:03:00.000Z Neumora Therapeutics appoints Joshua Pinto as CEO and Doron Sagman as CMO ahead of IND filing https://pharmadog.xyz/news/287399 pharmadog en 2026-08-20T14:49:44.000Z Scribe Therapeutics’ early-stage IPO surges 43% as epigenetic cholesterol drug enters clinic https://pharmadog.xyz/news/287419 pharmadog en 2026-08-20T14:38:32.000Z Trump administration nominates Heidi Overton as FDA commissioner after acting chief declines https://pharmadog.xyz/news/287375 pharmadog en 2026-08-20T14:34:02.000Z FDA expands TEMPO pilot with new digital health partners Limbic, Cadence and Dexcom https://pharmadog.xyz/news/287376 pharmadog en 2026-08-20T14:33:30.000Z Eli Lilly teams with Amplitude on taRNA vaccine platform as Otsuka ends psychedelic trial https://pharmadog.xyz/news/287168 pharmadog en 2026-08-20T13:38:04.000Z FDA approves Ultragenyx gene therapy and Regeneron ultra-rare disease drug https://pharmadog.xyz/news/287169 pharmadog en 2026-08-20T13:29:08.000Z American Cancer Society cancels wine and spirits gala amid conflict-of-interest concerns https://pharmadog.xyz/news/287124 pharmadog en 2026-08-20T13:23:46.000Z WuXi Bio sells majority stake in chromatography resin maker Bestchrom; Cabaletta adds new CDMO partner https://pharmadog.xyz/news/287125 pharmadog en 2026-08-20T13:16:42.000Z Epic expands AI tools for clinicians and patients, intensifying competition for health-tech startups https://pharmadog.xyz/news/286996 pharmadog en 2026-08-20T13:01:05.000Z Regeneron’s ultra-rare bone disorder drug receives U.S. approval after 30-year development https://pharmadog.xyz/news/286907 pharmadog en 2026-08-20T12:32:56.000Z Regeneron secures FDA approval for Pasatru, second U.S. treatment for rare bone disease FOP https://pharmadog.xyz/news/286908 pharmadog en 2026-08-20T12:08:34.000Z Ultragenyx secures first gene therapy approval for GSDIa as Sanfilippo asset decision pending https://pharmadog.xyz/news/286909 pharmadog en 2026-08-20T12:07:45.000Z Merck and Moderna’s melanoma vaccine shows positive Phase 3 results, boosting investor confidence https://pharmadog.xyz/news/286490 pharmadog en 2026-08-20T11:15:18.000Z FDA grants approval to Ultragenyx's Genglycos gene therapy for ultra-rare glycogen storage disorder https://pharmadog.xyz/news/286307 pharmadog en 2026-08-20T10:42:40.000Z Experts discuss persistent CMV challenges and new antiviral approaches for transplant patients https://pharmadog.xyz/news/286328 pharmadog en 2026-08-20T10:30:00.000Z Capricor Therapeutics likely faces FDA rejection of its Duchenne cell therapy https://pharmadog.xyz/news/286327 pharmadog en 2026-08-20T10:30:00.000Z Merck and Moderna report positive late-stage melanoma vaccine results, adding to 2026 cancer breakthrough year https://pharmadog.xyz/news/287350 pharmadog en 2026-08-20T09:59:00.000Z Chai Discovery partners with Bristol Myers Squibb to use AI for antibody discovery https://pharmadog.xyz/news/287351 pharmadog en 2026-08-20T09:29:00.000Z Eli Lilly partners with Amplitude Therapeutics to develop trans-amplifying RNA vaccines for infectious diseases https://pharmadog.xyz/news/287353 pharmadog en 2026-08-20T09:25:00.000Z Moderna's cancer vaccine boost lifts stock, sparks talk of Keytruda-like reach https://pharmadog.xyz/news/293242 pharmadog en 2026-08-20T09:18:00.000Z Pheast Therapeutics sticks with open R&D despite competitor Antengene moving ahead with anti‑CD24 trials https://pharmadog.xyz/news/285727 pharmadog en 2026-08-20T08:30:00.000Z Health systems deploy AI chatbots to streamline patient record review https://pharmadog.xyz/news/285729 pharmadog en 2026-08-20T08:30:00.000Z Experts warn protein restriction could harm older adults and GLP-1 patients https://pharmadog.xyz/news/285731 pharmadog en 2026-08-20T08:30:00.000Z US allocates $2 billion to faith-based health groups, highlighting shift toward faith-driven capital in global aid https://pharmadog.xyz/news/285728 pharmadog en 2026-08-20T08:30:00.000Z Capricor’s Duchenne drug deramiocel receives negative FDA advisory vote on heart outcome https://pharmadog.xyz/news/285730 pharmadog en 2026-08-20T08:30:00.000Z Experts urge DSM to list muscle dysmorphia as eating disorder to improve care for men https://pharmadog.xyz/news/287074 pharmadog en 2026-08-20T07:57:00.000Z FDA clears Vitestro's Aletta, first robotic blood draw device for U.S. clinics https://pharmadog.xyz/news/285264 pharmadog en 2026-08-20T07:00:00.000Z Layoffs hit over 1,300 workers across seven biopharma M&A deals in 2026 https://pharmadog.xyz/news/285265 pharmadog en 2026-08-20T07:00:00.000Z Biotech firms EMD Serono and Exelixis cut remote R&D staff as they enforce office return policies https://pharmadog.xyz/news/284467 pharmadog en 2026-08-20T04:04:00.000Z Pediatric rare cancer research draws steady investment despite biotech market volatility https://pharmadog.xyz/news/288983 pharmadog en 2026-08-20T04:00:00.000Z Medline recalls convenience kits with B. Braun bupivacaine component, urges correction before use https://pharmadog.xyz/news/290943 pharmadog en 2026-08-20T00:00:00.000Z EMA launches consultation on draft framework to speed adoption of data standards https://pharmadog.xyz/news/290944 pharmadog en 2026-08-20T00:00:00.000Z FDA approves Ultragenyx gene therapy for glycogen storage disorder; Overton faces confirmation hurdles https://pharmadog.xyz/news/290941 pharmadog en 2026-08-20T00:00:00.000Z Trump nominates Heidi Overton as FDA Commissioner as agency releases CGT Q&A guidance https://pharmadog.xyz/news/290942 pharmadog en 2026-08-20T00:00:00.000Z Experts call for modernizing rare disease evidence models using FDA plausible mechanism framework https://pharmadog.xyz/news/282863 pharmadog en 2026-08-19T21:33:10.000Z FDA grants accelerated approval to Genglycos, first therapy for glycogen storage disease type Ia https://pharmadog.xyz/news/283661 pharmadog en 2026-08-19T21:07:00.000Z B. Braun voluntarily recalls one lot of Excel Lactated Ringers IV solution over particulate contamination https://pharmadog.xyz/news/282303 pharmadog en 2026-08-19T20:03:20.000Z Trump administration nominates Heidi Overton as FDA commissioner https://pharmadog.xyz/news/282953 pharmadog en 2026-08-19T19:57:00.000Z Prince Bakery recalls several breads over undeclared milk and sesame allergens https://pharmadog.xyz/news/282175 pharmadog en 2026-08-19T19:31:45.000Z New CDC Director Erica Schwartz vows to speak truth to power and champion transparency